Login / Signup

Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis.

Thomas J MoorePhillip W WirtzJill N CurranG Caleb Alexander
Published in: BMJ open (2023)
A large proportion of adults using Schedule II stimulants are simultaneously exposed to one or more other CNS-active drugs, many with tolerance, withdrawal effects or potential for non-medical use. There are no approved indications and limited clinical trial testing of these multi-drug combinations, and discontinuation may be challenging.
Keyphrases
  • clinical trial
  • healthcare
  • drug induced
  • adverse drug
  • randomized controlled trial
  • phase ii
  • blood brain barrier
  • cerebrospinal fluid
  • bone marrow
  • stem cells
  • mesenchymal stem cells
  • cell therapy
  • double blind